3 active not recruiting, 1 completed, 1 not yet recruiting, 1 recruiting. 7 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Active not recruiting 3, Completed 1, Not yet recruiting 1, Recruiting 1, Terminated 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Lung Carcinoma: new trials by email Literature Review of Lung Carcinoma trials Research Report on Lung Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers Computed Tomography, Fludeoxyglucose F-18, Gallium Ga 68 FAPi-46 - Anal Carcinoma, Bladder Carcinoma | Phase 1 | Active not recruiting | Jonsson Comprehensive Cancer Center | 30 | 2025-08-01 | 2026-10-20 |
| Reinforced and Non-Reinforced Staple Lines in Fissureless Lobectomy Fissureless Lobectomy with Reinforced Staple Lines, Fissureless Lobectomy with Non-Reinforced Staple Lines - Lung, Lung Adenocarcinoma | Phase 1 | Not yet recruiting | Surrey Thoracic Surgery Group | 65 | 2025-01-01 | 2024-09-19 |
| Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery Near-Infrared Fluorescence Imaging, Panitumumab-IRDye800, Pharmacokinetic Study - Lung Carcinoma, Metastatic Malignant Neoplasm in the Lung | Phase 1 / Phase 2 | Recruiting | Stanford University | 30 | 2018-07-19 | 2026-10-05 |
| MUC1 Vaccine in Preventing Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer Laboratory Biomarker Analysis, MUC1 Peptide-Poly-ICLC Vaccine - Lung Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 50 | 2017-12-27 | 2026-07-31 |
| Iloprost in Preventing Lung Cancer in Former Smokers Iloprost, Placebo Administration, Quality-of-Life Assessment - Lung Carcinoma | Phase 1 | Completed | National Cancer Institute (NCI) | 34 | 2015-11-05 | 2023-11-28 |
| Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography - Advanced Malignant Solid Neoplasm, Anal Carcinoma | Phase 1 | Terminated | National Cancer Institute (NCI) | 79 | 2015-10-21 | 2026-01-21 |
| Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction Carboplatin, Laboratory Biomarker Analysis, Paclitaxel - Breast Carcinoma, Carcinoma of Unknown Primary | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 94 | 2011-06-20 | 2026-09-04 |
Lung Neoplasms (7) · Anus Neoplasms (2) · Breast Neoplasms (2) · Carcinoma, Transitional Cell (2) · Esophageal Neoplasms (2) · Neoplasm Metastasis (2) · Ovarian Neoplasms (2) · Testicular Neoplasms (2) · Adenocarcinoma of Lung (1) · Adrenal Gland Neoplasms (1) · Brain Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Medullary (1) · Carcinoma, Non-Small-Cell Lung (1) · Cholangiocarcinoma (1)
Lung Diseases (7) · Neoplasms (7) · Neoplasms by Site (7) · Respiratory Tract Diseases (7) · Respiratory Tract Neoplasms (7) · Thoracic Neoplasms (7) · Neoplasms by Histologic Type (4) · Carcinoma (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Gastrointestinal Diseases (3) · Gastrointestinal Neoplasms (3) · Genital Diseases (3) · Neoplasms, Glandular and Epithelial (3) · Urogenital Diseases (3)
Magnetic Resonance Spectroscopy (2) · Biopsy (1) · CTLA-4 Antigen (1) · Carboplatin (1) · FAPI-46 (1) · Fluorodeoxyglucose F18 (1) · Iloprost (1) · Ipilimumab (1) · Nivolumab (1) · Paclitaxel (1) · Pharmacogenomic Variants (1) · Specimen Handling (1) · Taxes (1) · veliparib (1)
National Cancer Institute (NCI) (4) · Jonsson Comprehensive Cancer Center (1) · Stanford University (1) · Surrey Thoracic Surgery Group (1)
United States (6) · Australia (1) · Canada (1)
Arjun Pennathur (1) · Hussein A Tawbi (1) · Jeremie Calais (1) · Lakshmi Rajdev (1) · Natalie Lui (1) · York E Miller (1)
PMID 33677480, PMID 37711198, PMID 37962072
N01CM00100 (1), N01CN00035 (1), N01CN00042 (1), P30CA015083 (1), P30CA047904 (1), P30CA060553 (1), U01CA062490 (1), U01CA062502 (1), U01CA062505 (1), U01CA069856 (1), U01CA070095 (1), U01CA099168 (1), U01CA121947 (1), UM1CA121947 (1), UM1CA186690 (1)